🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
The primary objective of this study is to evaluate the objective response r...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-10
Trial ID
NCT07351565
Treatments Being Tested
The purpose of this study is to assess overall survival of anti-tumor immun...
Status
Terminated
Location
St. Joseph Heritage Healthcare
Start Date
2013-02
Trial ID
NCT01774578
Treatments Being Tested
This was an open-label, multicenter, single-arm, Phase II trial of bevacizu...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00312728
Treatments Being Tested
This randomized phase III trial studies chemotherapy and bevacizumab to see...
Status
Completed
Location
Northeast Alabama Regional Medical Center
Start Date
2007-07-19
Trial ID
NCT00324805
This is a Single arm, Simon's two stage pilot study in which patients with ...
Status
Recruiting
Location
University of Illinois Cancer Center
Start Date
2024-12-16
Trial ID
NCT06576635
Treatments Being Tested
The aim of evaluating the efficacy and safety of cadonilimab combined with ...
Status
Recruiting
Location
Department of Medical Oncology, Central Hospital of Yichang City, the First Clinical Medical College of Three Gorges University
Start Date
2024-03-01
Trial ID
NCT06467500
Treatments Being Tested
This study will evaluate the efficacy, safety, and pharmacokinetics of immu...
Status
Terminated
Location
Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley
Start Date
2017-12-27
Trial ID
NCT03337698
The study aims at piloting the concept of customization of chemotherapy bas...
Status
Terminated
Location
King Abdul Aziz Medical City for National Guard Health Affairs
Start Date
2010-05
Trial ID
NCT01356368
Treatments Being Tested